I-Mab announced the appointment of John Long as the company's Chief Financial Officer, effective November 1, 2021. John Longwill report to Dr. Jingwu Zang, Founder and Chairman of I-Mab. He will join I-Mab's Board of Directors when the approval process is completed.Mr. Long is a seasoned business executive with more than 20 years of leadership experiences and strong track record in financial management, strategic planning, fundraising and capital market transactions. Mr. Long will oversee the Company's global finance team and lead capital markets activities (including dual listing efforts), investor relations and all aspects of financial management. He joins I-Mab as it pivots from an R&D-driven biotech towards a fully integrated biopharma company, where his extensive experience in managing complex operations at large corporations will be highly valuable.